21 Jan 2019 --- Symrise is looking to increase sales to between €5.5 billion (US$6.25 billion) and €6 billion (US$6.8 billion) as part of its 2025 strategy which will also see the company identifying and entering growth opportunities in the areas of naturalness and health. The company also plans targeted investments in additional organic growth and through strategic acquisitions and remains committed to generating more than half of its sales in emerging markets.